FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803660103> ?p ?o ?g. }

• W2803660103 endingPage "622" @default.
• W2803660103 startingPage "616" @default.
• W2803660103 abstract "Recently, safety guidelines for the use of intravascular iodinated contrast material have been updated, and the recommended threshold for giving prophylaxis to prevent contrast-induced nephropathy (CIN) has been reduced to estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m. Data on this population in the context of CIN, especially evidence for efficacy of the recommendation of prophylactic intravenous hydration, are lacking. The aim of the current study was to test implicit assumptions underlying the guideline update: (1) patients with eGFR <30 mL/min/1.73 m, as opposed to former high-risk patients with eGFR ≥30 mL/min/1.73 m, are at high risk of CIN and other unfavorable outcomes after intravascular iodinated contrast material administration; (2) prophylactic intravenous hydration mitigates this risk; and (3) the risk of administering prophylactic intravenous hydration does not outweigh the positive preventive effect.Retrospectively, data were collected from all patients with eGFR <30 mL/min/1.73 m referred for an elective procedure with intravascular iodinated contrast material administration and excluded from the AMACING trial (A MAastricht Contrast-Induced Nephropathy Guideline trial). We compared these patients with those prospectively included in the AMACING trial (with eGFR 30-59 mL/min/1.73 m and risk factors). Main outcomes were CIN (defined as an increase in serum creatinine by more than 25% or 44 μmol/L within 2-6 days postcontrast exposure), dialysis and mortality within 35 days postcontrast exposure, and complications of prophylactic intravenous hydration.A total of 28,803 patients referred for an elective procedure with intravascular iodinated contrast administration were prospectively screened for inclusion in the AMACING trial. One hundred fifty-seven (0.5%) patients had eGFR <30 mL/min/1.73 m, and 155 received intravascular iodinated contrast material. Standard prophylaxis was given to 119/155 of these patients. Data on 2- to 6-day serum creatinine, 35-day dialysis 35-day mortality, and complications of prophylactic intravenous hydration were available for 59/119 (50%), 118/119 (99%), 119/119 (100%), and 119/119 (100%) standard prophylaxis patients, respectively. Incidences in eGFR <30 mL/min/1.73 m versus AMACING patients are as follows: CIN 13.6% versus 2.7% (P = 0.0019); 35-day dialysis 0.9% versus 0.0% (P = 0.2646); 35-day mortality 9.2% versus 0.0% (P < 0.0001); complications of prophylactic intravenous hydration 5.9% versus 5.5% (P = 0.8529).Postcontrast incidences of CIN and mortality at 35 days are significantly higher in the population with eGFR <30 mL/min/1.73 m than in the former high-risk population with eGFR 30 to 59 mL/min/1.73 m, even after prophylactic intravenous hydration. The risk of complications of prophylactic intravenous hydration is similar and substantial in both populations. Obtaining evidence from a randomized trial that efficacy of prophylactic intravenous hydration outweighs the risk of complications is important but may not be feasible." @default.
• W2803660103 created "2018-06-01" @default.
• W2803660103 creator A5038435823 @default.
• W2803660103 creator A5040945596 @default.
• W2803660103 creator A5067497935 @default.
• W2803660103 creator A5069028114 @default.
• W2803660103 creator A5075110658 @default.
• W2803660103 date "2018-10-01" @default.
• W2803660103 modified "2023-10-02" @default.
• W2803660103 title "Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material" @default.
• W2803660103 cites W1605641829 @default.
• W2803660103 cites W1953613013 @default.
• W2803660103 cites W1964707780 @default.
• W2803660103 cites W1977037285 @default.
• W2803660103 cites W1996020381 @default.
• W2803660103 cites W2014642694 @default.
• W2803660103 cites W2018901137 @default.
• W2803660103 cites W2024297271 @default.
• W2803660103 cites W2032284109 @default.
• W2803660103 cites W2042074736 @default.
• W2803660103 cites W2045484411 @default.
• W2803660103 cites W2071197287 @default.
• W2803660103 cites W2074001063 @default.
• W2803660103 cites W2083207284 @default.
• W2803660103 cites W2083225471 @default.
• W2803660103 cites W2093019496 @default.
• W2803660103 cites W2095687684 @default.
• W2803660103 cites W2096235779 @default.
• W2803660103 cites W2100258934 @default.
• W2803660103 cites W2108554210 @default.
• W2803660103 cites W2124174298 @default.
• W2803660103 cites W2136223017 @default.
• W2803660103 cites W2138153676 @default.
• W2803660103 cites W2149286716 @default.
• W2803660103 cites W2152668905 @default.
• W2803660103 cites W2153104532 @default.
• W2803660103 cites W2153863833 @default.
• W2803660103 cites W2157218912 @default.
• W2803660103 cites W2162130726 @default.
• W2803660103 cites W2283001085 @default.
• W2803660103 cites W2299466555 @default.
• W2803660103 cites W2314879817 @default.
• W2803660103 cites W2421315571 @default.
• W2803660103 cites W2470481127 @default.
• W2803660103 cites W2472561972 @default.
• W2803660103 cites W2554807636 @default.
• W2803660103 cites W2554892549 @default.
• W2803660103 cites W2589882013 @default.
• W2803660103 cites W2748746126 @default.
• W2803660103 cites W2755739738 @default.
• W2803660103 cites W2767839334 @default.
• W2803660103 cites W2786550682 @default.
• W2803660103 cites W2791689004 @default.
• W2803660103 cites W4245191076 @default.
• W2803660103 doi "https://doi.org/10.1097/rli.0000000000000479" @default.
• W2803660103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29762257" @default.
• W2803660103 hasPublicationYear "2018" @default.
• W2803660103 type Work @default.
• W2803660103 sameAs 2803660103 @default.
• W2803660103 citedByCount "24" @default.
• W2803660103 countsByYear W28036601032018 @default.
• W2803660103 countsByYear W28036601032019 @default.
• W2803660103 countsByYear W28036601032020 @default.
• W2803660103 countsByYear W28036601032021 @default.
• W2803660103 countsByYear W28036601032022 @default.
• W2803660103 countsByYear W28036601032023 @default.
• W2803660103 crossrefType "journal-article" @default.
• W2803660103 hasAuthorship W2803660103A5038435823 @default.
• W2803660103 hasAuthorship W2803660103A5040945596 @default.
• W2803660103 hasAuthorship W2803660103A5067497935 @default.
• W2803660103 hasAuthorship W2803660103A5069028114 @default.
• W2803660103 hasAuthorship W2803660103A5075110658 @default.
• W2803660103 hasConcept C126322002 @default.
• W2803660103 hasConcept C126894567 @default.
• W2803660103 hasConcept C134018914 @default.
• W2803660103 hasConcept C141071460 @default.
• W2803660103 hasConcept C142724271 @default.
• W2803660103 hasConcept C151730666 @default.
• W2803660103 hasConcept C159641895 @default.
• W2803660103 hasConcept C2778569047 @default.
• W2803660103 hasConcept C2779222893 @default.
• W2803660103 hasConcept C2779343474 @default.
• W2803660103 hasConcept C2779978075 @default.
• W2803660103 hasConcept C2780182762 @default.
• W2803660103 hasConcept C2780306776 @default.
• W2803660103 hasConcept C2781184683 @default.
• W2803660103 hasConcept C2908647359 @default.
• W2803660103 hasConcept C44249647 @default.
• W2803660103 hasConcept C544519230 @default.
• W2803660103 hasConcept C555293320 @default.
• W2803660103 hasConcept C71924100 @default.
• W2803660103 hasConcept C82789193 @default.
• W2803660103 hasConcept C86803240 @default.
• W2803660103 hasConcept C99454951 @default.
• W2803660103 hasConceptScore W2803660103C126322002 @default.
• W2803660103 hasConceptScore W2803660103C126894567 @default.
• W2803660103 hasConceptScore W2803660103C134018914 @default.
• W2803660103 hasConceptScore W2803660103C141071460 @default.

• next